Congress warned against reversing US FDA's pre-emption authority
This article was originally published in RAJ Devices
Executive Summary
A US Senate committee has been warned that there could be “regulatory chaos” if proposed legislation that seeks to overturn the pre-emption authority of the US Food and Drug Administration over medical devices is signed into law1.